Managing high-risk CLL during transition to a new treatment era: stem cell transplantation or novel agents?

Peter Dreger, Johannes Schetelig, Niels Andersen, Paolo Corradini, Michel van Gelder, John Gribben, Eva Kimby, Mauricette Michallet, Carol Moreno, Stephan Stilgenbauer, Emili Montserrat

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)3841-3849
JournalBlood
Volume124
Issue number26
DOIs
Publication statusPublished - 18 Dec 2014

Cite this